A new trading day began on Monday, with RxSight Inc (NASDAQ: RXST) stock price up 3.46% from the previous day of trading, before settling in for the closing price of $44.83. RXST’s price has ranged from $28.54 to $66.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 201.89% over the last five years. Meanwhile, its annual earnings per share averaged 48.49%. With a float of $38.23 million, this company’s outstanding shares have now reached $40.30 million.
The firm has a total of 374 workers. Let’s measure their productivity. In terms of profitability, gross margin is 63.45%, operating margin of -28.24%, and the pretax margin is -22.17%.
RxSight Inc (RXST) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of RxSight Inc is 5.14%, while institutional ownership is 84.49%. The most recent insider transaction that took place on Nov 22 ’24, was worth 139,500. Before that another transaction happened on Nov 15 ’24, when Company’s insider sold 4,875 for $46.00, making the entire transaction worth $224,250. This insider now owns 42,246 shares in total.
RxSight Inc (RXST) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.13 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.49% per share during the next fiscal year.
RxSight Inc (NASDAQ: RXST) Trading Performance Indicators
Here are RxSight Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of RxSight Inc (RXST)
Analysing the last 5-days average volume posted by the [RxSight Inc, RXST], we can find that recorded value of 0.47 million was lower than the volume posted last year of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 48.00%. Additionally, its Average True Range was 2.11.
During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 42.70%, which indicates a significant increase from 29.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.63% in the past 14 days, which was higher than the 50.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $49.20, while its 200-day Moving Average is $52.74. Now, the first resistance to watch is $47.08. This is followed by the second major resistance level at $47.77. The third major resistance level sits at $48.80. If the price goes on to break the first support level at $45.35, it is likely to go to the next support level at $44.32. Should the price break the second support level, the third support level stands at $43.63.
RxSight Inc (NASDAQ: RXST) Key Stats
With a market capitalization of 1.87 billion, the company has a total of 40,304K Shares Outstanding. Currently, annual sales are 89,080 K while annual income is -48,610 K. The company’s previous quarter sales were 35,310 K while its latest quarter income was -6,340 K.